Benchmark (LON:BMK) Sets New 12-Month Low - Should You Sell?

Benchmark Holdings plc (LON:BMK - Get Free Report)'s stock price hit a new 52-week low on Wednesday . The stock traded as low as GBX 24 ($0.31) and last traded at GBX 25 ($0.32), with a volume of 79738 shares traded. The stock had previously closed at GBX 25.20 ($0.33).

Benchmark Price Performance

The company has a market cap of £192.73 million, a price-to-earnings ratio of -4.87, a price-to-earnings-growth ratio of -19.62 and a beta of 0.69. The company has a fifty day moving average price of GBX 27.79 and a two-hundred day moving average price of GBX 34.34. The company has a current ratio of 1.73, a quick ratio of 1.41 and a debt-to-equity ratio of 33.02.

Benchmark (LON:BMK - Get Free Report) last announced its quarterly earnings results on Wednesday, January 8th. The company reported GBX (5.99) (($0.08)) EPS for the quarter. Benchmark had a negative net margin of 43.67% and a negative return on equity of 16.05%. As a group, equities research analysts anticipate that Benchmark Holdings plc will post 0.9566873 EPS for the current fiscal year.

Benchmark Company Profile

Benchmark's mission is to enable aquaculture producers to improve their sustainability and profitability.We bring together biology and technology to develop innovative products which improve yield, quality and animal health and welfare for our customers. We do this by improving the genetic make-up, health and nutrition of their stock - from broodstock and hatchery through to nursery and grow out. Benchmark has a broad portfolio of products and solutions, including salmon eggs, live feed (artemia), diets and probiotics and sea lice treatments.